When we talk about cancer, the first thing that comes to our mind is the word, “deadly” Research is advanced now and with new advancements in medical science, the cure is now possible for cancer too. As per reports, cancer is the leading cause of death accounting for nearly 10 - 15 million deaths in 2021. As per WHO, one in 6 deaths is caused by cancer.
Here is some good news for people battling cancer and hoping to defeat cancer in their life. With advanced drug therapies, many clinical trials and research are being done to find a drug that can help beat cancer.
Researchers have designed such a drug, which has the power to eliminate this cancer up to 100 percent.
A New Hope for Cancer Cure
New miracles happen every day in the field of science and recently researchers have made a big achievement. Yes, researchers have made a big achievement in the fight against rectal cancer because they have developed a new drug, which has been found to be 100% effective in the treatment of this disease. Dostarlimab is a medicine that has come to light with its therapeutic effective properties against cancer.
The clinical trial is successful in 18 patients
In a clinical trial, a drug named Dostarlimab was tested on 18 patients for about 6 months, and when this trial ended, it was found that the tumor was cured. This was done in the USA, as reported by the New York Times.
These 18 patients have undergone various treatments before cancer including chemotherapy, radiation, and invasive therapy. Patients who reported having undergone these trials reported that they required no other treatment or therapy for cancer and their cancer was cured.
The solution to Cancer- Major breakthrough in the history of cancer
As per Dr. Luis. A. Diaz J of New York’s Memorial Sloan Kettering Cancer Center said that- “ The first time in history this has ever happened.” As per reports, the patient took the drug, Dostarlimab every three weeks for six months during the trial. Notably, all the cases were in the same stage of cancer and there was no further metastasis reported.
During the study, doctors also conducted a series of follow-up tests including a physical examination of the patients, MRI scans, and PET scans. The study was carried out by the pharmaceutical company GlaxoSmithKline. The study was published on June 6 in the New England Journal of Medicine.
What is Dostarlimab?
Dostarlimab is a drug in which the molecules are made by the lab and they work as a substitute for antibodies in the human body against cancer
Let us check whether these 18 patients can now pass through a second trial lab for the next step. According to experts, this is shocking and unbelievable.
Let us hope for a better future for cancer patients with advanced recovery and new clinical trails